Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wanda Honeycutt
A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Related publications
Phase-Ii Study of Dose Attenuated Schedule of Irinotecan, Capecitabine, and Celecoxib in Advanced Colorectal Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
"Poker" Association of Weekly Alternating 5-Fluorouracil, Irinotecan, Bevacizumab and Oxaliplatin (FIr-B/FOx) in First Line Treatment of Metastatic Colorectal Cancer: A Phase II Study
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
Oncology
Medicine
Cancer Research
Oncology
Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Capecitabine in Combination With Oxaliplatin and Bevacizumab (AXELOX) as 1st Line Treatment for Fit and Vulnerable Elderly Patients (Aged >70 Years) With Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
